CN111698994A - 治疗小麦敏感性的hmo混合物 - Google Patents

治疗小麦敏感性的hmo混合物 Download PDF

Info

Publication number
CN111698994A
CN111698994A CN201880088048.9A CN201880088048A CN111698994A CN 111698994 A CN111698994 A CN 111698994A CN 201880088048 A CN201880088048 A CN 201880088048A CN 111698994 A CN111698994 A CN 111698994A
Authority
CN
China
Prior art keywords
hmo
wheat
gluten
human
human milk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880088048.9A
Other languages
English (en)
Chinese (zh)
Inventor
L·K·比格斯奈斯
B·麦康奈尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glycom AS
Original Assignee
Glycom AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycom AS filed Critical Glycom AS
Publication of CN111698994A publication Critical patent/CN111698994A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/28—Oligosaccharides
    • A23V2250/282—Oligosaccharides, digestible
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN201880088048.9A 2017-11-30 2018-11-30 治疗小麦敏感性的hmo混合物 Pending CN111698994A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201700680 2017-11-30
DKPA201700680 2017-11-30
PCT/IB2018/059497 WO2019106618A1 (en) 2017-11-30 2018-11-30 Mixture of hmos for treating wheat sensitivity

Publications (1)

Publication Number Publication Date
CN111698994A true CN111698994A (zh) 2020-09-22

Family

ID=66664807

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880088048.9A Pending CN111698994A (zh) 2017-11-30 2018-11-30 治疗小麦敏感性的hmo混合物

Country Status (7)

Country Link
US (2) US11452736B2 (https=)
EP (1) EP3716984B1 (https=)
JP (1) JP7327724B2 (https=)
KR (2) KR20250058077A (https=)
CN (1) CN111698994A (https=)
ES (1) ES2987964T3 (https=)
WO (1) WO2019106618A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113939301A (zh) * 2019-06-05 2022-01-14 格礼卡姆股份公司 人乳寡糖用于在患有非乳糜泻小麦和/或麸质敏感性患者中治疗症状

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3782480A4 (en) 2018-03-29 2022-01-12 Morinaga Milk Industry Co., Ltd. NUTRITIONAL COMPOSITION, FOOD/DRINK COMPOSITION USING A NUTRITIONAL COMPOSITION AND MODIFIED MILK POWDER USING A NUTRITIONAL COMPOSITION
CN113194960A (zh) * 2018-12-19 2021-07-30 格礼卡姆股份公司 用于治疗使用低fodmap饮食的人的组合物和方法
JP2022132724A (ja) * 2021-03-01 2022-09-13 国立研究開発法人農業・食品産業技術総合研究機構 免疫グロブリンａ分泌促進剤
WO2022218960A1 (en) * 2021-04-13 2022-10-20 Frieslandcampina Nederland B.V. Nutritional composition for stimulationg bifidobacteria

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103402376A (zh) * 2010-12-31 2013-11-20 雅培制药有限公司 促进有益细菌生长的中性人乳寡糖
CN103763940A (zh) * 2010-12-31 2014-04-30 雅培制药有限公司 促进有益微生物群生长的益生菌和人乳寡糖的合益素组合
US20140187474A1 (en) * 2011-02-16 2014-07-03 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic use of mucin glycans
WO2014201037A2 (en) * 2013-06-10 2014-12-18 New York University Methods for manipulating immune responses by altering microbiota
CN104822279A (zh) * 2012-12-18 2015-08-05 雅培制药有限公司 缓减压力症状的人乳寡糖
CN105682664A (zh) * 2013-11-15 2016-06-15 雀巢产品技术援助有限公司 利用岩藻糖基化低聚糖预防或治疗非分泌型母亲诞下或喂养的婴儿的变态反应的组合物，尤其适用于有风险的婴儿或剖腹产婴儿
CN106794207A (zh) * 2014-10-29 2017-05-31 雀巢产品技术援助有限公司 使用罗伊氏乳杆菌在生命早期恢复微生物群生态失调
CN107019701A (zh) * 2010-12-31 2017-08-08 雅培制药有限公司 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
CN107106584A (zh) * 2014-12-08 2017-08-29 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
CN111683666A (zh) * 2017-12-22 2020-09-18 格礼卡姆股份公司 预防或减少伤害感受的包含hmo的组合物

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
WO2007101862A1 (en) 2006-03-09 2007-09-13 Centre National De La Recherche Scientifique (Cnrs) Method of producing sialylated oligosaccharides
EP2405524B1 (en) 2009-03-05 2015-10-07 Nissan Motor Co., Ltd. Bipolar secondary cell and method for producing the same
CN102459294A (zh) 2009-04-07 2012-05-16 格礼卡姆股份公司 2’-o-岩藻糖基乳糖的合成
ES2651067T3 (es) * 2009-07-06 2018-01-24 Children's Hospital Medical Center Inhibición de la inflamación con oligosacáridos de la leche
EP3241836B1 (en) 2010-02-19 2024-10-30 Glycom A/S Polymorph of a tetrasaccharide containing nacetyl-lactosamine
WO2011100979A1 (en) 2010-02-19 2011-08-25 Glycom A/S Production of 6'-o-sialyllactose and intermediates
AU2011278236A1 (en) 2010-07-16 2013-02-07 Glycom A/S Derivatization of oligosaccharides
WO2012113404A1 (en) 2011-02-21 2012-08-30 Glycom A/S Novel glycosyl phosphites
CN103443113A (zh) 2011-03-18 2013-12-11 格力康公司 新型含岩藻糖的糖类衍生物的合成
WO2012155916A1 (en) 2011-05-13 2012-11-22 Glycom A/S Manufacture of lacto-n-tetraose
CN103562401A (zh) 2011-05-13 2014-02-05 格力康公司 产生人乳寡糖(hmo)或其前体的方法
CN103562214B9 (zh) 2011-05-13 2016-12-14 格力康公司 人乳寡糖(hmo)或其前体的多样化
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
EP2760875A4 (en) 2011-09-30 2015-08-26 Glycom As SYNTHESIS OF HMO NUCLEAR STRUCTURES
WO2013091660A1 (en) 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
WO2013139344A1 (en) 2012-03-20 2013-09-26 Glycom A/S Synthesis of the trisaccharide 3-o-fucosyllactose and intermediates thereof
EP2935300B1 (en) * 2012-12-18 2025-01-22 Glycom A/S Novel polymorphs of lnnt
EP3212197A4 (en) * 2014-10-29 2018-07-11 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
US20170000830A1 (en) * 2015-07-01 2017-01-05 Rakesh Saini Compositions for Relieving the Symptoms of Gluten Sensitivity and Methods of Use Thereof
ES2886951T3 (es) 2015-09-14 2021-12-21 Glycom As Composición para su uso en la modulación de la microbiota
DK3452050T3 (da) 2016-05-05 2023-02-20 Glycom As Composition comprising hmos for the treatment of noninfectious diarrhoea
JP2020513014A (ja) * 2017-04-07 2020-04-30 チルドレンズ ホスピタル メディカル センター ２’−フコシルラクトース化合物による炎症性腸疾患の治療
US11602545B2 (en) * 2017-12-05 2023-03-14 Glycom A/S Human milk oligosaccharides for treating migraine

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103402376A (zh) * 2010-12-31 2013-11-20 雅培制药有限公司 促进有益细菌生长的中性人乳寡糖
CN103763940A (zh) * 2010-12-31 2014-04-30 雅培制药有限公司 促进有益微生物群生长的益生菌和人乳寡糖的合益素组合
CN107019701A (zh) * 2010-12-31 2017-08-08 雅培制药有限公司 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
US20140187474A1 (en) * 2011-02-16 2014-07-03 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic use of mucin glycans
CN104822279A (zh) * 2012-12-18 2015-08-05 雅培制药有限公司 缓减压力症状的人乳寡糖
WO2014201037A2 (en) * 2013-06-10 2014-12-18 New York University Methods for manipulating immune responses by altering microbiota
CN105682664A (zh) * 2013-11-15 2016-06-15 雀巢产品技术援助有限公司 利用岩藻糖基化低聚糖预防或治疗非分泌型母亲诞下或喂养的婴儿的变态反应的组合物，尤其适用于有风险的婴儿或剖腹产婴儿
CN106794207A (zh) * 2014-10-29 2017-05-31 雀巢产品技术援助有限公司 使用罗伊氏乳杆菌在生命早期恢复微生物群生态失调
CN107106584A (zh) * 2014-12-08 2017-08-29 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
CN111683666A (zh) * 2017-12-22 2020-09-18 格礼卡姆股份公司 预防或减少伤害感受的包含hmo的组合物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANDREW J TARR，等: "The prebiotics 3\'Sialyllactose and 6\'Sialyllactose diminish stressor-induced anxiety-like behavior and colonic microbiota alterations: Evidence for effects on the gut-brain axis" *
CARLO CATASSI，等: "The Overlapping Area of Non-Celiac Gluten Sensitivity (NCGS) and Wheat-Sensitive Irritable Bowel Syndrome (IBS): An Update" *
EMMA ELISON，等: "Oral supplementation of healthy adults with 2\'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota" *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113939301A (zh) * 2019-06-05 2022-01-14 格礼卡姆股份公司 人乳寡糖用于在患有非乳糜泻小麦和/或麸质敏感性患者中治疗症状

Also Published As

Publication number Publication date
EP3716984A1 (en) 2020-10-07
KR20250058077A (ko) 2025-04-29
US20210169907A1 (en) 2021-06-10
EP3716984C0 (en) 2024-03-20
JP7327724B2 (ja) 2023-08-16
EP3716984A4 (en) 2021-06-16
ES2987964T3 (es) 2024-11-18
BR112020010863A2 (pt) 2020-11-10
JP2021504421A (ja) 2021-02-15
EP3716984B1 (en) 2024-03-20
US11452736B2 (en) 2022-09-27
WO2019106618A1 (en) 2019-06-06
KR20200096263A (ko) 2020-08-11
US11986487B2 (en) 2024-05-21
US20230014752A1 (en) 2023-01-19

Similar Documents

Publication Publication Date Title
JP7301093B2 (ja) 過敏性腸症候群の治療のための合成組成物および方法
US11291677B2 (en) Synthetic composition for microbiota modulation
US11986487B2 (en) Mixture of HMOS for treating wheat sensitivity
US11278558B2 (en) Synthetic composition for microbiota modulation
CN111683665A (zh) 用于微生物群调节的人乳寡糖及其合成组合物
JP7833397B2 (ja) 妊婦の細菌叢を改善するためのｈｍｏの混合物
CN107106584A (zh) 用于治疗代谢障碍的合成组合物
US11890293B2 (en) Synthetic composition for treating metabolic disorders
JP2021526143A (ja) 自己免疫疾患を処置するためのｈｍｏの混合物
CN113939301A (zh) 人乳寡糖用于在患有非乳糜泻小麦和/或麸质敏感性患者中治疗症状
US10835544B2 (en) Synthetic composition for regulating satiety
BR112020010863B1 (pt) Oligossacarídeos do leite humano para tratamento da sensibilidade ao trigo

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination